Charmacy Pharmaceutical Co., Ltd. — Share Issue/Capital Change 2017

Jun 2, 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [66 x 54] intentionally omitted <==

CHARMACY PHARMACEUTICAL CO., LTD. 創美藥業股份有限公司

(a joint stock limited liability company established in the People’s Republic of China)

(Stock code: 2289)

VOLUNTARY ANNOUNCEMENT PROPOSED A-SHARE ISSUE

The board of directors (the “ Board ”) of Charmacy Pharmaceutical Co., Ltd. (the “ Company ”, together with its subsidiaries, the “ Group ”) is pleased to announce that the Group is presently considering and exploring the possibility of the issuance of ordinary shares of the Company to be traded in RMB on the Shanghai Stock Exchange or the Shenzhen Stock Exchange (the “ Proposed A-Share Issue ”), subject to the final decision of the Board. Based on the above, the Company has appointed CSC Financial Co., Ltd. (中信建投證券股份有限公司) as the offering counselling agency for the purpose of the Proposed A-Share Issue. The Company shall comply with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”), and shall make further announcement(s) on the material update and development in respect of the Proposed A-Share Issue in due course or in accordance with the Listing Rules and/or the requirements of other applicable laws and regulations.

The shareholders and potential investors of the Company should note that the Proposed A-Share Issue is subject to, among others, the final decision of the Board and the shareholders of the Company as well as the approval from China Securities Regulatory Commission and other relevant regulatory authorities. The shareholders and potential investors of the Company shall

– 1 –

therefore be aware of the fact that there is no assurance as to whether or when the Proposed A-Share Issue will proceed. Accordingly, the shareholders and potential investors of the Company shall exercise cautions when dealing or planning to deal in any securities of the Company, and shall only rely on the information published by the Company. If any person is in doubt as to his/her/its condition or as to the action to be taken, he/she/it is strongly advised to consult his/her/its own professional advisor.

By Order of the Board Charmacy Pharmaceutical Co., Ltd. Yao Chuanglong Chairman

Hong Kong, 2 June 2017

As at the date of this announcement, the executive Directors of the Company are Mr. Yao Chuanglong, Ms. Zheng Yuyan, Mr. Fan Jianbo and Mr. Lin Zhixiong; the non-executive Director of the Company is Ms. You Zeyan; and the independent non-executive Directors of the Company are Mr. Wan Chi Wai Anthony, Mr. Zhou Tao and Mr. Guan Jian (also known as Guan Suzhe).

– 2 –